[8] [9] [10] [11] Although reduced GLP-1 secretion has previously been associated with attenuated incretin effect in patients with type 2 diabetes, further research indicates that GLP-1 secretion in patients with type 2 diabetes does not differ from healthy subjects
Tirzepatide is also less effective at reducing body weight in T2D patients compared to patients without (15.7% weight loss, SURMOUNT-2 and 22.5% weight loss, SURMOUNT-1, respectively)
What the Future Holds for Cagrilintide Ongoing studies are assessing long-term cardiovascular outcomes , weight loss durability, and real-world adherence
Understanding the half-life of your specific medication, combined with guidance from a trusted provider like RXIV Infusions, ensures youre getting the most effective and safe results
Self-medication is not advisable
Follow with your other serums or your moisturizer to seal in all the benefits